The Indian Journal of Pediatrics

, Volume 77, Issue 12, pp 1446–1447 | Cite as

Vancomycin Resistant Enterococci in Neonatal ICU- A Rising Menace

  • Ojasvini Choudhry
  • Geeta GathwalaEmail author
  • Jagjit Singh
Scientific Letters to the Editor


Minimum Inhibitory Concentration Vancomycin Linezolid Surveillance Culture Oxazolidinones 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Torres-Viera C, Dembry L-M. Approaches to vancomycin-resistant enterococci. Curr Opin Infect Dis. 2004;17:541–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Beneri CA, Nicolau DP, Seiden HS, Rubin LG. Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin—containing regimen. Infect Drug Resist. 2008;1:9–11.CrossRefGoogle Scholar
  3. 3.
    Duchon J, Graham P, Della-Latta P, et al. Epidemiology of Enterococci in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2008;29:374–6.CrossRefPubMedGoogle Scholar
  4. 4.
    Se YB, Chun HJ, Yi HJ, Kim DW, Ko Y Incidence and risk factor of infection caused by vancomycin-resistant enterococcus colonization in neurosurgical intensive care unit patients. J Korean Neurosurg Soc. 2009;46:123–9.Google Scholar
  5. 5.
    Corti G, Cinelli R, Paradisi F. Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic. Int J Antimicrob Agents. 2000;4:527–30.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2010

Authors and Affiliations

  • Ojasvini Choudhry
    • 1
  • Geeta Gathwala
    • 1
    • 2
    Email author
  • Jagjit Singh
    • 1
  1. 1.Neonatal Division, Departments of Pediatrics, Pt. B.D.Sharma PGIMSUniversity of Health Sciences RohtakRohtakIndia
  2. 2.6J/8, Medical enclave, Pt.B.D.Sharma PGIMSRohtakIndia

Personalised recommendations